icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
 
 
 
CRV431 and CMX157 (TXL; tenofovir exalidex): Anti-HBV combination effects in vitro between a cyclophilin inhibitor and a nucleotide prodrug
 
 
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
 
R. FOSTER1, D. TREPANIER1, D. URE1 , J. GREYTOK1, J.L. KULP2, P. GALLAY3 1 Contravir Pharmaceuticals Inc, Edison, New Jersey, USA and Edmonton, Alberta, Canada 2 Baruch S. Blumberg Institute, Doylestown, Pennsylvania, USA 3 The Scripps Research Institute, La Jolla, California, USA

0505171

0505172

 

0505173

0505174

0505175

 

0505176